Jerry Gurwitz to Cost-Benefit Analysis
This is a "connection" page, showing publications Jerry Gurwitz has written about Cost-Benefit Analysis.
Connection Strength
0.853
-
Ito K, Chapman R, Pearson SD, Tafazzoli A, Yaffe K, Gurwitz JH. Evaluation of the Cost-effectiveness of Drug Treatment for Alzheimer Disease in a Simulation Model That Includes Caregiver and Societal Factors. JAMA Netw Open. 2021 10 01; 4(10):e2129392.
Score: 0.687
-
Goldberg R, Gore JM, Barton B, Gurwitz J. Individual and composite study endpoints: separating the wheat from the chaff. Am J Med. 2014 May; 127(5):379-84.
Score: 0.101
-
Subramanian S, Hoover S, Gilman B, Field TS, Mutter R, Gurwitz JH. Computerized physician order entry with clinical decision support in long-term care facilities: costs and benefits to stakeholders. J Am Geriatr Soc. 2007 Sep; 55(9):1451-7.
Score: 0.065